[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1032378T3 - Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme - Google Patents

Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme

Info

Publication number
DK1032378T3
DK1032378T3 DK98964471T DK98964471T DK1032378T3 DK 1032378 T3 DK1032378 T3 DK 1032378T3 DK 98964471 T DK98964471 T DK 98964471T DK 98964471 T DK98964471 T DK 98964471T DK 1032378 T3 DK1032378 T3 DK 1032378T3
Authority
DK
Denmark
Prior art keywords
diol
alpha
mixture
skin diseases
hydroxy acid
Prior art date
Application number
DK98964471T
Other languages
English (en)
Inventor
Agneta Ganemo
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Application granted granted Critical
Publication of DK1032378T3 publication Critical patent/DK1032378T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98964471T 1997-11-25 1998-11-25 Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme DK1032378T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203681 1997-11-25
PCT/EP1998/007759 WO1999026617A1 (en) 1997-11-25 1998-11-25 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases

Publications (1)

Publication Number Publication Date
DK1032378T3 true DK1032378T3 (da) 2002-04-15

Family

ID=8228970

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98964471T DK1032378T3 (da) 1997-11-25 1998-11-25 Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme

Country Status (22)

Country Link
US (1) US6399082B1 (da)
EP (1) EP1032378B1 (da)
CN (1) CN1140266C (da)
AT (1) ATE213939T1 (da)
AU (1) AU754420B2 (da)
BG (1) BG64743B1 (da)
BR (1) BR9815016A (da)
CA (1) CA2310049C (da)
CZ (1) CZ290165B6 (da)
DE (1) DE69804130T2 (da)
DK (1) DK1032378T3 (da)
ES (1) ES2174533T3 (da)
HK (1) HK1034194A1 (da)
HU (1) HU226065B1 (da)
IS (1) IS2147B (da)
NO (1) NO320100B1 (da)
NZ (1) NZ504458A (da)
PL (1) PL190023B1 (da)
PT (1) PT1032378E (da)
SK (1) SK284505B6 (da)
TR (1) TR200001486T2 (da)
WO (1) WO1999026617A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5778367A (en) * 1995-12-14 1998-07-07 Network Engineering Software, Inc. Automated on-line information service and directory, particularly for the world wide web
US6841539B1 (en) * 1998-05-21 2005-01-11 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
US6410036B1 (en) * 2000-05-04 2002-06-25 E-L Management Corp. Eutectic mixtures in cosmetic compositions
WO2002096374A2 (en) 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20070189989A1 (en) * 2006-02-16 2007-08-16 Cantwell Maggie Y Cosmetic compositions and methods of making and using the compositions
EP1996021B1 (en) 2006-02-28 2017-12-13 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
CA2719853A1 (en) * 2008-03-25 2009-10-01 Paloma Pharmaceuticals, Inc. Methods of treating fibrotic disorders
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
ES2404156T3 (es) * 2009-04-13 2013-05-24 Vanangamudi Subramaniam SULUR Una crema medicinal con ácido fusídico hecha utilizando fusidato de sodio e incorporando un biopolímero y el proceso para hacerla
EP2429559A4 (en) * 2009-05-08 2013-08-14 Allmedic Pty Ltd TREATMENT OF PAIN AND / OR INFLAMMATION AS WELL AS TREATMENT AND PREVENTION OF SKIN OR SLICING DISEASES OR TROUBLES
BR112013011156B1 (pt) * 2010-11-04 2022-05-03 442 Ventures, Llc Composição e método para tratar condições de pele
WO2012112791A1 (en) 2011-02-16 2012-08-23 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
GB2540764A (en) * 2015-07-24 2017-02-01 Fontus Health Ltd Topical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5407958A (en) * 1993-07-30 1995-04-18 Beauticontrol Cosmetics, Inc. Therapeutic skin composition
CA2168870A1 (en) * 1993-09-15 1995-03-23 Anthony Vincent Rawlings Skin care method and composition

Also Published As

Publication number Publication date
AU1965999A (en) 1999-06-15
IS2147B (is) 2006-09-15
HU226065B1 (hu) 2008-04-28
NO320100B1 (no) 2005-10-24
EP1032378B1 (en) 2002-03-06
IS5505A (is) 2000-05-23
NO20002649L (no) 2000-07-24
PT1032378E (pt) 2002-07-31
US6399082B1 (en) 2002-06-04
DE69804130T2 (de) 2002-07-25
NZ504458A (en) 2002-03-01
DE69804130D1 (de) 2002-04-11
SK284505B6 (sk) 2005-05-05
CA2310049C (en) 2008-02-19
HUP0100066A2 (hu) 2001-08-28
PL190023B1 (pl) 2005-10-31
TR200001486T2 (tr) 2001-07-23
ATE213939T1 (de) 2002-03-15
BG104470A (en) 2001-03-30
WO1999026617A1 (en) 1999-06-03
CZ20001920A3 (cs) 2001-04-11
AU754420B2 (en) 2002-11-14
NO20002649D0 (no) 2000-05-24
BG64743B1 (bg) 2006-02-28
CA2310049A1 (en) 1999-06-03
CN1280495A (zh) 2001-01-17
HK1034194A1 (en) 2001-10-19
CN1140266C (zh) 2004-03-03
SK7432000A3 (en) 2001-05-10
CZ290165B6 (cs) 2002-06-12
BR9815016A (pt) 2000-10-03
EP1032378A1 (en) 2000-09-06
HUP0100066A3 (en) 2006-07-28
ES2174533T3 (es) 2002-11-01
PL340679A1 (en) 2001-02-12

Similar Documents

Publication Publication Date Title
DK1032378T3 (da) Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
ID21761A (id) Komposisi perawatan kulit yang mengandung asam dan retinoid
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
DK0711140T3 (da) Antimykotisk opløsning til negle
IT8519382A0 (it) Composizioni analgesiche e antiinfiammatorie comprendenti difeni dramina e metodi di usare le stesse
BR9403783A (pt) Uso de uma composição cosmética
DE3681353D1 (de) Bindemittel fuer keramik sowie herstellung von keramikformkoerpern.
IT1285770B1 (it) Composti corticoidei
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
ATE78171T1 (de) Gangliosidgemisch zur verwendung als therapeutisches hilfsmittel zur schmerzunterdrueckung bei peripheren neuropathien.
DE69723769D1 (de) Direkteinspritzung von Sauerstoff in der Herstellung von Salpetersäure
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
NO902104L (no) Kosmetisk blanding.
GB9626472D0 (en) New use of comt inhibitors
AU7028598A (en) Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
PT1135154E (pt) Melhoria da foliculogenese
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
EP0211434A3 (de) Rektale Dosierungsformen für Ceftriaxon
DE3767055D1 (de) N-(2,6-dichlor-m-tolyl)anthranilsaeure (mechlophenaminsaeure) enthaltenden gel-arzneiform zur verwendung in der lokaltherapie.
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances
DE69637416D1 (de) Topische anwendung von opioiden, wie morphin, zur linderung von juckreiz und hautkrankheiten sowie hautreizungen
ATE55249T1 (de) Minocylin in stabiler form enthaltendes mittel zur behandlung periodontaler erkrankungen.
SU809821A1 (ru) β-(3-Диметиламинопропионил)-β-фенилгидразид бензиловой кислоты, проявляющий анальгетическую и противовоспалительную активность